Lysyl oxidase is induced by cell density-mediated cell cycle suppression via RB-E2F1-HIF-1α axis

Cell Structure and Function

Volumn 38, Issue 1, 2013, Pages 9-14

  Goto, Takaaki M ^a   Arima, Yoshimi ^a   Nagano, Osamu ^a   Saya, Hideyuki ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Breast cancer; Cell cycle; Cell density; E2F1; Lysyl oxidase

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEIN LYSINE 6 OXIDASE; RETINOBLASTOMA TUMOR SUPPRESSOR PROTEIN; TRANSCRIPTION FACTOR E2F1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL DENSITY; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME INDUCTION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS REGULATION; UPREGULATION;

BREAST NEOPLASMS; CELL COUNT; CELL CYCLE CHECKPOINTS; CELL DIVISION; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; E2F1 TRANSCRIPTION FACTOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; PROTEIN-LYSINE 6-OXIDASE;

EID: 84872505950     PISSN: 03867196     EISSN: 13473700     Source Type: Journal    
DOI: 10.1247/csf.12023     Document Type: Article

References (19)

1. Arima, Y., Inoue, Y., Shibata, T., Hayashi, H., Nagano, O., Saya, H., and Taya, Y. 2008. Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transition. Cancer Research, 68: 5104-5112.
2. Arima, Y., Hayashi, N., Hayashi, H., Sasaki, M., Kai, K., Sugihara, E., Abe, E., Yoshida, A., Mikami, S., Nakamura, S., and Saya, H. 2012a. Loss of p16 expression is associated with the stem cell characteristics of surface markers and therapeutic resistance in estrogen receptor-negative breast cancer. International Journal of Cancer, 130: 2568-2579.
3. Arima, Y., Hayashi, H., Sasaki, M., Hosonaga, M., Goto, T.M., Chiyoda, T., Kuninaka, S., Shibata, T., Ohata, H., Nakagama, H., Taya, Y., and Saya, H. 2012b. Induction of ZEB by inactivation of RB is a key determinant of the mesenchymal phenotype of breast cancer. The Journal of Biological Chemistry, 287: 7896-7906.
4. Chen, H.-Z., Tsai, S.-Y., and Leone, G. 2009. Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nature reviews. Cancer, 9: 785-797.
5. Day, M.L., Zhao, X., Vallorosi, C.J., Putzi, M., Powell, C.T., Lin, C., and Day, K.C. 1999. E-cadherin mediates aggregation-dependent survival of prostate and mammary epithelial cells through the retinoblastoma cell cycle control pathway. The Journal of Biological Chemistry, 274: 9656-9664.
6. Dayan, F., Bilton, R.L., Laferrière, J., Trottier, E., Roux, D., Pouyssegur, J., and Mazure, N.M. 2009. Activation of HIF-1alpha in exponentially growing cells via hypoxic stimulation is independent of the Akt/mTOR pathway. Journal of Cellular Physiology, 218: 167-174.
7. Erler, J.T., Bennewith, K.L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T.A., Jeffrey, S.S., and Giaccia, A.J. 2006. Lysyl oxidase is essential for hypoxia-induced metastasis. Nature, 440: 1222-1226.
8. Erler, J.T., Bennewith, K.L., Cox, T.R., Lang, G., Bird, D., Koong, A., Le, Q.-T., and Giaccia, A.J. 2009. Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell, 15: 35-44.
9. Giacinti, C. and Giordano, A. 2006. RB and cell cycle progression. Oncogene, 25: 5220-5227.
10. Hirota, S.A, Beck, P.L., and MacDonald, J.A. 2009. Targeting hypoxiainducible factor-1 (HIF-1) signaling in therapeutics: implications for the treatment of inflammatory bowel disease. Recent Patents on Inflammation & Allergy Drug Discovery, 3: 1-16.
11. Hubbi, M.E., Luo, W., Baek, J.H., and Semenza, G.L. 2011. MCM Proteins Are Negative Regulators of Hypoxia-Inducible Factor 1. Molecular Cell, 42: 700-712.
12. Kagan, H.M. and Li, W. 2003. Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell. Journal of Cellular Bio-chemistry, 88: 660-672.
13. Khidr, L. and Chen, P.-L. 2006. RB, the conductor that orchestrates life, death and differentiation. Oncogene, 25: 5210-5219.
14. Levental, K.R., Yu, H., Kass, L., Lakins, J.N., Egeblad, M., Erler, J.T., Fong, S.F.T., Csiszar, K., Giaccia, A., Weninger, W., Yamauchi, M., Gasser, D.L., and Weaver, V.M. 2009. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell, 139: 891-906.
15. Lieberman, M.A. and Glaser, L. 1981. Density-Dependent Regulation of Cell Growth: An Example of a Cell-Cell Recognition Phenomenon. Journal of Membrane Biology, 63: 1-11.
16. Liu, F. and Korc, M. 2012. Cdk4/6 Inhibition Induces Epithelial-Mesenchymal Transition and Enhances Invasiveness in Pancreatic Cancer Cells. Molecular Cancer Therapeutics, 11: 2138-2148.
17. O'Donnell, K.A., Wentzel, E.A., Zeller, K.I., Dang, C.V., and Mendell, J.T. 2005. c-Myc-regulated microRNAs modulate E2F1 expression. Nature, 435: 839-843.
18. Pickering, M.T., Stadler, B.M., and Kowalik, T.F. 2009. miR-17 and miR-20a temper an E2F1-induced G1 checkpoint to regulate cell cycle progression. Oncogene, 28: 140-145.
19. Sheta, E.A., Trout, H., Gildea, J.J., Harding, M.A., and Theodorescu, D. 2001. Cell density mediated pericellular hypoxia leads to induction of HIF-1α via nitric oxide and Ras/MAP kinase mediated signaling pathways. Oncogene, 20: 7624-7634.